Lockard O, Harmon C, Nolph K, Irvin W
Ann Intern Med. 1976 Sep;85(3):333-5. doi: 10.7326/0003-4819-85-3-333.
A 25-year-old white man with gout and nephropathy and with a previous reaction to allopurinol was given a trial dose of oxypurinol. He developed malaise, a generalized erythematous reaction with edema, pruritus, and emesis; this was clinically identical to the reaction he experienced with allopurinol. When the patient's lymphocytes were exposed in vitro to oxypurinol and allopurinol, increased DNA synthesis was observed, suggesting an immunologic basis for the reaction. This patient indicates that clinical cross reactivity to allopurinol and oxypurinol does occur and may be of an immunologic basis. There is a need for additional xanthine oxidase inhibitors for such patients.
一名25岁患有痛风和肾病且曾对别嘌醇有过反应的白人男性接受了氧嘌呤醇的试验剂量。他出现了不适、伴有水肿、瘙痒和呕吐的全身性红斑反应;这在临床上与他使用别嘌醇时所经历的反应相同。当患者的淋巴细胞在体外暴露于氧嘌呤醇和别嘌醇时,观察到DNA合成增加,提示该反应存在免疫基础。该患者表明别嘌醇和氧嘌呤醇之间确实会发生临床交叉反应,且可能具有免疫基础。对于这类患者,需要更多的黄嘌呤氧化酶抑制剂。